251 related articles for article (PubMed ID: 20164315)
1. Disposition of soy isoflavones in normal human breast tissue.
Bolca S; Urpi-Sarda M; Blondeel P; Roche N; Vanhaecke L; Possemiers S; Al-Maharik N; Botting N; De Keukeleire D; Bracke M; Heyerick A; Manach C; Depypere H
Am J Clin Nutr; 2010 Apr; 91(4):976-84. PubMed ID: 20164315
[TBL] [Abstract][Full Text] [Related]
2. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
3. Distribution of soy-derived phytoestrogens in human breast tissue and biological fluids.
Maubach J; Depypere HT; Goeman J; Van der Eycken J; Heyerick A; Bracke ME; Blondeel P; De Keukeleire D
Obstet Gynecol; 2004 May; 103(5 Pt 1):892-8. PubMed ID: 15121562
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Comparison of Soy Isoflavone Extracts in Human Plasma.
Rodríguez-Morató J; Farré M; Pérez-Mañá C; Papaseit E; Martínez-Riera R; de la Torre R; Pizarro N
J Agric Food Chem; 2015 Aug; 63(31):6946-53. PubMed ID: 26186408
[TBL] [Abstract][Full Text] [Related]
5. Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults.
Gardner CD; Chatterjee LM; Franke AA
J Nutr Biochem; 2009 Mar; 20(3):227-34. PubMed ID: 18602820
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women.
Anupongsanugool E; Teekachunhatean S; Rojanasthien N; Pongsatha S; Sangdee C
BMC Clin Pharmacol; 2005 Mar; 5():2. PubMed ID: 15743537
[TBL] [Abstract][Full Text] [Related]
8. Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males.
Vergne S; Bennetau-Pelissero C; Lamothe V; Chantre P; Potier M; Asselineau J; Perez P; Durand M; Moore N; Sauvant P
Br J Nutr; 2008 Feb; 99(2):333-44. PubMed ID: 17678570
[TBL] [Abstract][Full Text] [Related]
9. Disposition of hop prenylflavonoids in human breast tissue.
Bolca S; Li J; Nikolic D; Roche N; Blondeel P; Possemiers S; De Keukeleire D; Bracke M; Heyerick A; van Breemen RB; Depypere H
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2(0 2):S284-94. PubMed ID: 20486208
[TBL] [Abstract][Full Text] [Related]
10. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage.
Shelnutt SR; Cimino CO; Wiggins PA; Ronis MJ; Badger TM
Am J Clin Nutr; 2002 Sep; 76(3):588-94. PubMed ID: 12198004
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.
Setchell KD; Brown NM; Desai PB; Zimmer-Nechimias L; Wolfe B; Jakate AS; Creutzinger V; Heubi JE
J Nutr; 2003 Apr; 133(4):1027-35. PubMed ID: 12672914
[TBL] [Abstract][Full Text] [Related]
13. Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.
Lu LW; Chen NW; Nayeem F; Ramanujam VS; Kuo YF; Brunder DG; Nagamani M; Anderson KE
Clin Nutr; 2018 Dec; 37(6 Pt A):1862-1870. PubMed ID: 29183775
[TBL] [Abstract][Full Text] [Related]
14. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
Gardner CD; Oelrich B; Liu JP; Feldman D; Franke AA; Brooks JD
Prostate; 2009 May; 69(7):719-26. PubMed ID: 19180569
[TBL] [Abstract][Full Text] [Related]
15. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas.
Irvine CH; Shand N; Fitzpatrick MG; Alexander SL
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1462S-1465S. PubMed ID: 9848517
[TBL] [Abstract][Full Text] [Related]
16. Determination of the isoflavone composition and estrogenic activity of commercial dietary supplements based on soy or red clover.
Andres S; Hansen U; Niemann B; Palavinskas R; Lampen A
Food Funct; 2015 Jun; 6(6):2017-25. PubMed ID: 26023053
[TBL] [Abstract][Full Text] [Related]
17. Absolute bioavailability of isoflavones from soy protein isolate-containing food in female BALB/c mice.
Andrade JE; Twaddle NC; Helferich WG; Doerge DR
J Agric Food Chem; 2010 Apr; 58(7):4529-36. PubMed ID: 20225898
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Isoflavones in Soybeans for Women with Menopausal Syndrome: An Overview.
Chen LR; Chen KH
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809928
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, sources, and predictors of soy consumption in breast cancer.
Lammersfeld CA; King J; Walker S; Vashi PG; Grutsch JF; Lis CG; Gupta D
Nutr J; 2009 Jan; 8():2. PubMed ID: 19159489
[TBL] [Abstract][Full Text] [Related]
20. NTP-CERHR expert panel report on the developmental toxicity of soy infant formula.
McCarver G; Bhatia J; Chambers C; Clarke R; Etzel R; Foster W; Hoyer P; Leeder JS; Peters JM; Rissman E; Rybak M; Sherman C; Toppari J; Turner K
Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):421-68. PubMed ID: 21948615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
